Search Results1-6 of  6

  • Cutsem Eric van ID: 9000010410932

    Articles in CiNii:1

    • The best manuscript: Open-label phase 3 trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer[含 解説者コメント] (2007)
  • Van Cutsem Eric ID: 9000305623355

    Articles in CiNii:1

    • HER2 screening data from ToGA : targeting HER2 in gastric and gastroesophageal junction cancer (2015)
  • Van Cutsem Eric ID: 9000333206835

    Articles in CiNii:1

    • COLORECTAL AND GASTRIC CANCER IN 2015 : The development of new agents and molecular classifications (2016)
  • Van Cutsem Eric ID: 9000390405164

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • Van Cutsem Eric ID: 9000403259752

    Articles in CiNii:1

    • Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer (2019)
  • CUTSEM Eric VAN ID: 9000259334839

    Department of Digestive Oncology (2013 from CiNii)

    Articles in CiNii:1

    • Significant impact of transient deterioration of renal function on dosimetry in PRRT (2013)
Page Top